https://thepharmadata.com/aptatek-biosciences-announces-financing/ 2026-09-30T10:51:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/09/Aptatek-Biosciences-Announces-Financing-to-Advance-PheCheck™-Clinical-Program.webp https://thepharmadata.com/alnylams-amvuttra-play-by-play-initiative/ 2026-09-30T11:00:28+05:30 https://thepharmadata.com/wp-content/uploads/2026/09/Alnylams-AMVUTTRA®-‘Play-by-Play-Initiative-Highlights-Former-Athletes-Stories-to-Raise-Awareness-of-ATTR-CM-Signs.webp https://thepharmadata.com/gardner-medical-instruments-receives-fda/ 2026-09-30T11:04:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/09/Gardner-Medical-Instruments-Receives-FDA-Registration-for-Ventubation™-System-Earns-EMS-EXPO-Award-Nomination.webp https://thepharmadata.com/restorixhealth-announces-2026-center-recognition/ 2026-09-30T11:09:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/09/RestorixHealth-Announces-2026-Center-Recognition-Awards_11zon.webp https://thepharmadata.com/trilink-biotechnologies-secures-china-patent/ 2026-09-30T11:14:45+05:30 https://thepharmadata.com/wp-content/uploads/2026/09/TriLink-BioTechnologies-Secures-China-Patent-for-CleanCap®-Technology-Expanding-Global-IP-Protection.webp https://thepharmadata.com/blue-matter-launches-behavioral-science-center/ 2026-10-01T10:04:45+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Blue-Matter-Launches-Behavioral-Science-Center-of-Excellence_11zon.webp https://thepharmadata.com/cytoagents-presents-new-preclinical-cto1681/ 2026-10-01T10:08:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/CytoAgents-Presents-New-Preclinical-CTO1681-Data-at-2026-EADV-Congress_11zon.webp https://thepharmadata.com/specialtycares-neuromonitoring-training/ 2026-10-01T10:20:08+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/SpecialtyCares-Neuromonitoring-Training-Program-Earns-CAAHEP-Accreditation.webp https://thepharmadata.com/inquis-medical-launches-first-360-directional/ 2026-10-01T10:39:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Inquis-Medical-Launches-First-360°-Directional-Aspiration-Thrombectomy-Catheter-for-Pulmonary-Embolism.webp https://thepharmadata.com/study-links-avoiding-sweets-during-antibiotic/ 2026-10-01T10:45:49+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Study-Links-Avoiding-Sweets-During-Antibiotic-Treatment-to-Better-Gut-Microbiome-Health_11zon.webp https://thepharmadata.com/fresenius-kabi-receives-vizient-pharmacy/ 2026-10-01T10:50:33+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Fresenius-Kabi-Receives-Vizient-Pharmacy-Strategic-Programs-Excellence-Award_11zon.webp https://thepharmadata.com/argonaut-manufacturing-services-appoints-j-d/ 2026-10-01T10:56:20+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Argonaut-Manufacturing-Services-Appoints-J.D.-Mowery-to-Board-of-Directors_11zon.webp https://thepharmadata.com/qurient-publishes-q901-cdk7-inhibitor-data-in/ 2026-10-01T11:01:25+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Qurient-Publishes-Q901-CDK7-Inhibitor-Data-in-Science-Advances_11zon.webp https://thepharmadata.com/icus-review-challenges-state-law-myth/ 2026-10-01T11:07:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/ICUS-Review-Challenges-State-Law-Myth-on-Sonographer-Use-of-Ultrasound-Contrast-Agents.webp https://thepharmadata.com/medical-affairs-leaders-convene-in/ 2026-10-03T01:31:50+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Medical-Affairs-Technology-and-Innovation-Symposium-3.png https://thepharmadata.com/samsung-bioepis-and-teva-expand-partnership/ 2026-10-03T10:11:10+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Samsung-Bioepis-and-Teva-Expand-Partnership-to-Develop-Up-to-Six-Biosimilar-Candidates_11zon.webp https://thepharmadata.com/blue-matter-launches-behavioral-science-center-2/ 2026-10-03T10:19:53+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Blue-Matter-Launches-Behavioral-Science-Center-of-Excellence-to-Predict-Health-Care-Decisions-in-Biopharma_11zon.webp https://thepharmadata.com/summit-therapeutics-partners-with-astrazeneca/ 2026-10-03T10:30:35+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Summit-Therapeutics-Partners-with-AstraZeneca-and-Daiichi-Sankyo-to-Evaluate-Ivonescimab-Plus-Datroway-in-Clinical-Trial_11zon.webp https://thepharmadata.com/italfarmaco-and-jcr-pharma-partner-on-novel/ 2026-10-03T10:35:13+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Italfarmaco-and-JCR-Pharma-Partner-on-Novel-Hunter-Syndrome-Therapy_11zon.webp https://thepharmadata.com/angiodynamics-and-pert-consortium-name-jacobi/ 2026-10-03T10:39:52+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/AngioDynamics-and-PERT-Consortium-Name-Jacobi-Hospital-ALPHA-PE-Research-Award-Recipient_11zon.webp https://thepharmadata.com/listerine-launches-oral-care-counts-on-world/ 2026-10-03T10:48:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/LISTERINE®-Launches-Oral-Care-Counts-on-World-Smile-Day-as-Global-Oral-Disease-Cases-Reach-3.73-Billion.webp https://thepharmadata.com/verastem-oncology-to-present-new-ramp-201-data/ 2026-10-03T10:56:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Verastem-Oncology-to-Present-New-RAMP-201-Data-on-Avutometinib-in-LGSOC-at-IGCS-2026_11zon.webp https://thepharmadata.com/iliad-biotechnologies-publishes-pediatric-bpze1/ 2026-10-03T11:00:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/ILiAD-Biotechnologies-Publishes-Pediatric-BPZE1-Phase-2b-Data-in-The-Lancet-Infectious-Diseases_11zon.webp https://thepharmadata.com/orano-med-opens-europes-first-lead-212-alpha/ 2026-10-03T11:04:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Orano-Med-Opens-Europes-First-Lead-212-Alpha-Therapy-Production-Facility.webp https://thepharmadata.com/genedx-introduces-easy-order-at-aap-2026/ 2026-10-03T11:10:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/GeneDx-Introduces-Easy-Order-at-AAP-2026-to-Simplify-Genomic-Testing-in-Pediatric-Care_11zon.webp https://thepharmadata.com/singleton-associates-and-bcbs-texas-sign-long/ 2026-10-03T11:15:08+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Singleton-Associates-and-BCBS-Texas-Sign-Long-Term-Radiology-Care-Agreement_11zon.webp https://thepharmadata.com/travere-to-present-filspari-kidney-week-2026/ 2026-10-03T11:21:40+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Travere-to-Present-FILSPARI-Data-in-IgAN-and-FSGS-at-ASN-Kidney-Week-2026_11zon.webp https://thepharmadata.com/pfizers-litfulo-improves-facial-and-body/ 2026-10-03T11:26:41+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Pfizers-LITFULO-Improves-Facial-and-Body-Repigmentation-in-Nonsegmental-Vitiligo.webp https://thepharmadata.com/roquette-to-showcase-end-to-end-pharmaceutical/ 2026-10-03T11:32:49+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Roquette-to-Showcase-End-to-End-Pharmaceutical-Solutions-for-Patient-Centric-Formulations-at-CPHI-Milan-2026_11zon.webp https://thepharmadata.com/bayer-to-invest-2-2-billion-in-new-u-s/ 2026-10-03T11:38:18+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Bayer-to-Invest-2.2-Billion-in-New-U.S.-Manufacturing-Site_11zon.webp https://thepharmadata.com/alliance-foundation-trials-and-natera-launch/ 2026-10-06T10:15:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Alliance-Foundation-Trials-and-Natera-Launch-Phase-III-NAVIGATE-Trial-in-Breast-Cancer_11zon.webp https://thepharmadata.com/i2pure-strengthens-leadership-and-scientific/ 2026-10-06T10:33:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/I2Pure-Strengthens-Leadership-and-Scientific-Team-with-Three-Key-Hires_11zon.webp https://thepharmadata.com/catalent-launches-u-s-gene-to-drug-substance/ 2026-10-06T10:43:10+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Catalent-Launches-U.S.-Gene-to-Drug-Substance-Program-for-Complex-Molecules_11zon.webp https://thepharmadata.com/biocentury-grand-rounds-heads-to-houston/ 2026-10-06T10:52:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/BioCentury-Grand-Rounds-Heads-to-Houston-for-Sixth-Investor-and-Executive-Meeting_11zon-scaled.webp https://thepharmadata.com/epicrispr-reports-positive-six-month-epi-321/ 2026-10-06T10:57:51+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Epicrispr-Reports-Positive-Six-Month-EPI-321-Data-in-FSHD-Patients_11zon.webp https://thepharmadata.com/ge-healthcare-to-acquire-sofie-biosciencesexpand/ 2026-10-06T11:18:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/GE-HealthCare-to-Acquire-SOFIE-Biosciences-to-Expand-U.S.-PET-Radiopharmaceutical-Supply_11zon.webp https://thepharmadata.com/exthymic-secures-up-to-25m-arpa-h-contract-for/ 2026-10-06T11:24:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Exthymic-Secures-Up-to-25M-ARPA-H-Contract-for-Hospital-Based-Cell-Therapy-Production_11zon.webp https://thepharmadata.com/neurolife-appoints-christopher-coburn/ 2026-10-07T10:00:26+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/NeuroLife-Appoints-Christopher-Coburn-and-Matthew-Thomas-to-Board_11zon.webp https://thepharmadata.com/shape-memory-medical-receives-anvisa-approval/ 2026-10-07T10:20:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Shape-Memory-Medical-Receives-ANVISA-Approval-for-IMPEDE-Embolization-Plug-Family-in-Brazil_11zon.webp https://thepharmadata.com/nitto-avecia-receives-third-consecutive-fda/ 2026-10-07T10:28:17+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Nitto-Avecia-Receives-Third-Consecutive-FDA-Inspection-with-No-Action-Indicated_11zon.webp https://thepharmadata.com/city-of-hope-appoints-new-presidents-for-cancer/ 2026-10-07T10:34:44+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/City-of-Hope-Appoints-New-Presidents-for-Cancer-Centers-in-Arizona-and-Atlanta_11zon.webp https://thepharmadata.com/dexcom-u-enters-season-5-as-diabetes-stigma/ 2026-10-07T10:41:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Dexcom-U-Enters-Season-5-as-Diabetes-Stigma-Fades_11zon.webp https://thepharmadata.com/invivoscribe-expands-molecular-clonality-testing/ 2026-10-07T10:47:25+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Invivoscribe-Expands-Molecular-Clonality-Testing-Portfolio-with-LymphoTrack-Flex-Suite_11zon.webp https://thepharmadata.com/roslinct-secures-7-25m-grant-for-digital-cell/ 2026-10-07T10:52:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/RoslinCT-Secures-7.25M-Grant-for-Digital-Cell-Therapy-Manufacturing.webp https://thepharmadata.com/bridge-neurotech-butterfly-network-partner-on/ 2026-10-07T10:58:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Bridge-Neurotech-Butterfly-Network-Partner-on-Non-Invasive-Brain-Computer-Interface.jpg https://thepharmadata.com/medisca-and-euroapi-partner-to-expand-api-access/ 2026-10-08T10:43:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Medisca-and-EUROAPI-Partner-to-Expand-API-Access-for-Pharmaceutical-Compounding_11zon.webp https://thepharmadata.com/pearl-diagnostics-publishes-clinical-studies/ 2026-10-08T10:49:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Pearl-Diagnostics-Publishes-Clinical-Studies-Supporting-FDA-Clearance-of-MycoMEIA®-Aspergillus-Assay.webp https://thepharmadata.com/pfizers-tukysa-regimen-wins-fda-approval/ 2026-10-08T10:55:20+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Pfizers-TUKYSA-Regimen-Wins-FDA-Approval-for-Front-Line-Maintenance-in-HER2-Metastatic-Breast-Cancer.webp https://thepharmadata.com/seaport-therapeutics-doses-first-patient-phase-2/ 2026-10-08T11:06:52+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Seaport-Therapeutics-Doses-First-Patient-in-Phase-2a-Trial-of-GlyphAgo™-for-Generalized-Anxiety-Disorder-and-Sleep-Disturbance.webp https://thepharmadata.com/life-sciences-bc-selects-companies-and-mentors/ 2026-10-08T11:10:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Life-Sciences-BC-Selects-Companies-and-Mentors-for-Seventh-Annual-Investor-Readiness-Program_11zon.webp https://thepharmadata.com/glaukos-reports-positive-three-year-epioxa/ 2026-10-08T11:15:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Glaukos-Reports-Positive-Three-Year-Epioxa®-Results-in-Keratoconus.webp https://thepharmadata.com/inbrain-and-minigraph-develop-implantation/ 2026-10-08T11:23:41+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/INBRAIN-and-MINIGRAPH-Develop-Robotic-Implantation-for-Graphene-Brain-Computer-Interfaces_11zon.webp https://thepharmadata.com/fda-approves-genentechs-tecentriq-combination/ 2026-10-12T16:24:59+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/FDA-Approves-Genentechs-Tecentriq-Combination-for-Stage-III-Colon-Cancer-Adjuvant-Treatment.webp https://thepharmadata.com/ascensia-partners-with-sava-to-advance-innovativ/ 2026-10-12T16:29:54+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Ascensia-Partners-with-Sava-to-Advance-Innovative-Microsensor-Technology_11zon.webp https://thepharmadata.com/seaport-therapeutics-presents-phase-1/ 2026-10-12T16:34:07+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Seaport-Therapeutics-Presents-New-GlyphAgo™-Phase-1-Pharmacokinetic-Data-at-ECNP-Congress.webp https://thepharmadata.com/glaukos-reports-positive-phase-4-results-for/ 2026-10-12T16:37:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Glaukos-Reports-Positive-Phase-4-Results-for-iDose®-TR-Combined-with-Cataract-Surgery.webp https://thepharmadata.com/secretome-therapeutics-to-present-phase-1-stm-01/ 2026-10-12T16:44:32+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Secretome-Therapeutics-to-Present-Phase-1-STM-01-Data-in-HFpEF-at-HFSA-Meeting_11zon.webp https://thepharmadata.com/affinia-therapeutics-aftx-201-and-upbeat2026/ 2026-10-12T16:48:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Affinia-Therapeutics-AFTX-201-and-UPBEAT™-Trial-Featured-at-HFSA-2026.webp https://thepharmadata.com/corcym-reports-positive-perceval-plus-heart/ 2026-10-12T16:52:45+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Corcym-Reports-Positive-Perceval-Plus-Heart-Valve-Data-With-Up-to-7-Year-Follow-Up_11zon.webp https://thepharmadata.com/bioaffinity-technologies-closes-4-million/ 2026-10-12T16:56:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/bioAffinity-Technologies-Closes-4-Million-Registered-Direct-Offering-and-Concurrent-Private-Placement_11zon.webp https://thepharmadata.com/final-mint-study-results-support-real-world/ 2026-10-13T09:56:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Final-MINT-Study-Results-Support-Real-World-Effectiveness-of-Poteligeo®-in-MF-and-Sezary-Syndrome.webp https://thepharmadata.com/biomag-ll-study-completes-enrollment/ 2026-10-13T10:10:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/BIOMAG™-LL-Study-Completes-Enrollment-for-Freesolve™-Magnesium-Scaffold.webp https://thepharmadata.com/bausch-lomb-names-thomas-j-appio-interim-2026/ 2026-10-13T10:15:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Bausch-Lomb-Names-Thomas-J.-Appio-Interim-CEO-Raises-2026-Guidance-Expectations_11zon.webp https://thepharmadata.com/bristol-myers-squibbs-phase-3-aloft-ipf-trial/ 2026-10-13T10:20:01+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Bristol-Myers-Squibbs-Phase-3-ALOFT-IPF-Trial-of-Admilparant-Meets-Primary-Endpoint-in-IPF-Patients.webp https://thepharmadata.com/tg-therapeutics-publishes-five-year-comparative/ 2026-10-13T10:24:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/TG-Therapeutics-Publishes-Five-Year-Comparative-Analysis-of-BRIUMVI-Ocrelizumab-and-Ofatumumab-in-Relapsing-MS_11zon.webp https://thepharmadata.com/catalent-and-mantra-sign-commercial-supply/ 2026-10-13T10:29:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Catalent-and-Mantra-Sign-Commercial-Supply-Agreement-for-Single-Serve-Oral-Gel-Portfolio_11zon.webp https://thepharmadata.com/stoke-therapeutics-presents-stk-002-aao-2026/ 2026-10-13T10:34:44+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Stoke-Therapeutics-Presents-STK-002-Disease-Modifying-Data-in-ADOA-at-AAO-2026_11zon.webp https://thepharmadata.com/rubedo-life-sciences-reports-rls-1496-phase-1b/ 2026-10-13T10:39:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Rubedo-Life-Sciences-Reports-RLS-1496-Phase-1b-Data-Showing-Reduced-Skin-Epigenetic-Age-and-Inflammation_11zon.webp https://thepharmadata.com/vitalis-selects-applied-biocode-for-molecular/ 2026-10-13T10:45:07+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/VITALiS-Selects-Applied-BioCode-for-Molecular-Gastrointestinal-Pathogen-Panel-Testing_11zon.webp https://thepharmadata.com/tortugas-neuroscience-reports-positive-phase-2b/ 2026-10-13T10:51:51+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Tortugas-Neuroscience-Reports-Positive-Phase-2b-Results-for-Obuprazine-in-Schizophrenia_11zon.webp https://thepharmadata.com/fortitude-biomedicines-to-present-ftb-918-axial/ 2026-10-14T12:11:07+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Fortitude-Biomedicines-to-Present-FTB-918-Axial-Spondyloarthritis-Data-at-ACR-Convergence-2026_11zon.webp https://thepharmadata.com/ignitedata-and-realtime-partner-to-expand/ 2026-10-14T12:26:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/IgniteData-and-RealTime-Partner-to-Expand-Clinical-Trial-Data-Transfer-in-Global-Markets_11zon.webp https://thepharmadata.com/gc-biopharma-to-present-expanded-igns-2026/ 2026-10-14T12:31:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/GC-Biopharma-to-Present-Expanded-ALYGLO®-Phase-3-Safety-Data-at-IgNS-2026.webp https://thepharmadata.com/immunis-named-semifinalist-in-1-5m-healthy/ 2026-10-14T12:40:44+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Immunis-Named-Semifinalist-in-1.5M-Healthy-Longevity-Global-Competition_11zon.webp https://thepharmadata.com/cure-first-expands-cancer-precision-medicine/ 2026-10-14T12:47:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Cure-First-Expands-Cancer-Precision-Medicine-Access-with-New-Washington-Lab_11zon.webp https://thepharmadata.com/medicinal-genomics-launches-next-day-pathogen/ 2026-10-14T12:53:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Medicinal-Genomics-Launches-Next-Day-Pathogen-Testing-for-Supplements_11zon.webp https://thepharmadata.com/curi-bio-expands-curiverse-with-new-disease/ 2026-10-15T09:55:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Curi-Bio-Expands-Curiverse™-With-New-Disease-Models-and-Casting-Solutions.webp https://thepharmadata.com/proteintech-announces-leadership-appointments/ 2026-10-15T10:00:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Proteintech-Announces-New-Leadership-Appointments_11zon.webp https://thepharmadata.com/kazmira-therapeutics-partners-with-carevalidate/ 2026-10-15T10:11:18+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Kazmira-Therapeutics-Partners-with-CareValidate-to-Expand-Telemedicine-Access-to-Prescription-Cannabis-Therapy_11zon.webp https://thepharmadata.com/independent-assessment-finds-brightfocus-330m/ 2026-10-15T10:29:15+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Independent-Assessment-Finds-BrightFocus-Foundations-330M-Investment-in-High-Risk-Science-Delivering-Results.webp https://thepharmadata.com/healthcare-leaders-urge-integration-oral-health/ 2026-10-15T10:38:49+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Healthcare-Leaders-Urge-Integration-of-Oral-Health-into-Routine-Medical-Care_11zon.webp https://thepharmadata.com/baszucki-group-supports-new-study-bringing/ 2026-10-15T10:51:45+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/New-Study-Expands-Access-to-Ketogenic-Therapy-for-Bipolar-Disorder-in-Rural-Alabama_11zon.webp https://thepharmadata.com/portal-innovations-venture-team-publishes/ 2026-10-15T10:57:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Portal-Innovations-Venture-Team-Publishes-Analysis-of-Capital-Efficiency-in-Emerging-Biotech-Markets_11zon.webp https://thepharmadata.com/med-institute-joins-novelnas-arpa-h-funded/ 2026-10-15T11:04:53+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/MED-Institute-Joins-Novelnas-ARPA-H-Funded-PULSE-Consortium-to-Advance-Wearable-Biosensing-Technology.webp https://thepharmadata.com/beone-medicines-showcases-rapid-growth-esmo-2026/ 2026-10-21T10:29:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/BeOne-Medicines-Showcases-Rapid-Growth-of-Its-Solid-Tumor-Portfolio-at-ESMO-2026_11zon.webp https://thepharmadata.com/roquette-showcases-comprehensive-pharmsci-360/ 2026-10-21T10:34:05+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Roquette-Showcases-Comprehensive-Excipient-Solutions-and-Technical-Expertise-at-AAPS-PharmSci-360-2026_11zon.webp https://thepharmadata.com/new-research-uncovers-immune-mechanism-driving/ 2026-10-21T10:53:08+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/New-Research-Uncovers-Immune-Mechanism-Driving-Radiation-Induced-Lung-Damage_11zon.webp https://thepharmadata.com/neurogene-to-present-key-differentiators-ngn-401/ 2026-10-21T11:34:56+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Neurogene-to-Present-Key-Differentiators-of-NGN-401-for-Rett-Syndrome-at-ESGCT-33rd-Annual-Congress_11zon.webp https://thepharmadata.com/orogen-therapeutics-targeting-il-17-jak1-tyk2/ 2026-10-21T11:44:54+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Orogen-Therapeutics-Selects-Two-Development-Candidates-for-Immune-Diseases-Targeting-IL-17-and-JAK1TYK2_11zon.webp https://thepharmadata.com/johnson-johnson-launches-shockwave-c2/ 2026-10-21T11:51:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Johnson-Johnson-Launches-Next-Generation-Shockwave™-C2-Aero-Fly-Coronary-IVL-Catheter-to-Halve-Treatment-Time.webp https://thepharmadata.com/algia-pharma-reports-positive-ind-enabling-study/ 2026-10-21T11:56:33+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Algia-Pharma-Reports-Positive-IND-Enabling-Study-Results-for-AlgiaPak®-Non-Opioid-Acute-Pain-Treatment.webp https://thepharmadata.com/parse-biosciences-launches-evercode-max-expand/ 2026-10-21T12:02:19+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Parse-Biosciences-Launches-Evercode-MAX-to-Expand-Single-Cell-Profiling-Capacity-and-Flexibility_11zon.webp https://thepharmadata.com/bionyra-pharma-reports-positive-interim-phase-1/ 2026-10-21T12:38:53+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Bionyra-Pharma-Reports-Positive-Interim-Phase-1-Results-for-Long-Acting-Anti-TL1A-Antibody-BYN-002_11zon.webp https://thepharmadata.com/cosette-pharmaceuticals-secures-fda-approval/ 2026-10-21T12:44:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Cosette-Pharmaceuticals-Secures-FDA-Approval-for-EVOXAC®-Oral-Solution-Marking-First-NDA-Approval.webp https://thepharmadata.com/savillex-expands-bioprocessing-portfolio/ 2026-10-21T12:50:32+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Savillex-Expands-Bioprocessing-Portfolio-with-Entegris-Life-Sciences-Acquisition_11zon.webp https://thepharmadata.com/shionogi-presents-idweek-2026-u-s-real-world/ 2026-10-22T10:07:52+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Shionogi-Presents-IDWeek-2026-U.S.-Real-World-Data-Showing-Improved-Outcomes-with-Early-Fetroja®Fetcroja®-Treatment-in-Respiratory-Infections.webp https://thepharmadata.com/angiodynamics-announces-direct-study-results/ 2026-10-22T10:15:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/AngioDynamics-Announces-DIRECT-Study-Results-Publication-and-New-Category-I-CPT-Code-for-Pancreatic-IRE_11zon.webp https://thepharmadata.com/heartbeam-announces-early-completion-headstart/ 2026-10-22T10:19:32+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/HeartBeam-Announces-Early-Completion-of-HEADSTART-ACS-Enrollment-in-Largest-Heart-Attack-Detection-Study-Using-Its-Technology_11zon.webp https://thepharmadata.com/tg-therapeutics-presents-new-clinical-data/ 2026-10-22T10:25:31+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/TG-Therapeutics-Presents-New-Clinical-Data-Across-Its-Multiple-Sclerosis-Portfolio-at-MSToronto-2026_11zon.webp https://thepharmadata.com/edwards-lifesciences-receives-fda-approval/ 2026-10-22T10:31:51+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Edwards-Lifesciences-Receives-FDA-Approval-for-PASCAL-Precision-System-to-Expand-Treatment-Options-for-Tricuspid-Valve-Disease_11zon.webp https://thepharmadata.com/viiv-healthcare-highlights-five-year-u-s-real/ 2026-10-22T10:38:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/ViiV-Healthcare-Highlights-Five-Year-U.S.-Real-World-Evidence-Supporting-Cabenuvas-Long-Term-Effectiveness-and-Treatment-Persistence.webp https://thepharmadata.com/immunis-wins-grand-prize-in-national-academy/ 2026-10-22T10:43:45+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Immunis-Wins-Grand-Prize-in-National-Academy-of-Medicines-Healthy-Longevity-Global-Competition.webp https://thepharmadata.com/future-health-and-bridge-for-billions-launch/ 2026-10-22T10:50:40+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Future-Health-and-Bridge-for-Billions-Launch-Programme-to-Advance-Health-Entrepreneurship-in-Emerging-Markets_11zon.webp https://thepharmadata.com/merck-and-moderna-to-present-phase-3-esmo-2026/ 2026-10-23T12:24:32+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Merck-and-Moderna-to-Present-Phase-3-INTerpath-001-Results-at-ESMO-2026_11zon.webp https://thepharmadata.com/future-health-and-bridge-for-billions-launch-2/ 2026-10-23T12:30:25+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Future-Health-and-Bridge-for-Billions-Launch-Programme-to-Boost-Health-Entrepreneurship-in-Emerging-Markets_11zon.webp https://thepharmadata.com/nutromics-unveils-world-first-real-creatinine/ 2026-10-23T12:36:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Nutromics-Unveils-World-First-Real-Time-Creatinine-Data-at-ASN-Kidney-Week_11zon.webp https://thepharmadata.com/drug-farm-reports-positive-preclinical-df-003/ 2026-10-23T12:40:35+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Drug-Farm-Reports-Positive-Preclinical-DF-003-Results-for-Kidney-Inflammation-and-Fibrosis_11zon.webp https://thepharmadata.com/gilead-to-acquire-hcxt-2001-expanding-its-ibd/ 2026-10-23T12:45:09+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Gilead-to-Acquire-HCXT-2001-Expanding-Its-IBD-Inflammation-Pipeline_11zon.webp https://thepharmadata.com/zai-lab-secures-250-million-private-placement/ 2026-10-23T12:50:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Zai-Lab-Secures-250-Million-in-Private-Placement_11zon.webp https://thepharmadata.com/mundipharma-presents-additional-at-idweek-2026/ 2026-10-23T12:56:17+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Mundipharma-Presents-Additional-Phase-III-ReSPECT-Results-at-IDWeek-2026_11zon.webp https://thepharmadata.com/salubris-biotherapeutics-reports-updated-1b2/ 2026-10-24T10:00:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Salubris-Biotherapeutics-Reports-Updated-Phase-1b2-Data-for-5T4-Targeted-ADC-JK06-at-ESMO-2026_11zon.webp https://thepharmadata.com/brenus-pharma-reports-promising-safety-stc-1010/ 2026-10-24T10:05:38+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Brenus-Pharma-Reports-Promising-Safety-and-T-Cell-Activation-Data-for-STC-1010-With-Two-Complete-Responses-in-First-Line-MSS-Metastatic-Colorectal-Cancer_11zon.webp https://thepharmadata.com/neuromodulation-publishes-36-month-core-vns/ 2026-10-24T10:10:40+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Neuromodulation-Publishes-36-Month-CORE-VNS-Results-Showing-Sustained-Benefits-of-LivaNovas-VNS-Therapy-for-Drug-Resistant-Epilepsy.webp https://thepharmadata.com/convergent-therapeutics-present-positive-phase-2/ 2026-10-24T10:24:54+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Convergent-Therapeutics-to-Present-Positive-Phase-2-CONV01-α-Results-at-ESMO-2026.webp https://thepharmadata.com/beone-medicines-reports-sustained-survival/ 2026-10-24T10:31:46+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/BeOne-Medicines-Reports-Sustained-Survival-Benefits-with-TEVIMBRA-ZIIHERA-in-First-Line-HER2-Positive-Gastroesophageal-Cancer_11zon.webp https://thepharmadata.com/bristol-myers-squibb-presents-1-breakfree-2/ 2026-10-24T10:41:04+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Bristol-Myers-Squibb-Presents-Phase-1-BREAKFREE-2-Results-for-Zolacabtagene-Autoleucel-in-Progressive-Multiple-Sclerosis-at-MSToronto-2026_11zon.webp https://thepharmadata.com/tg-therapeutics-presents-phase-1-azer-cel-data/ 2026-10-24T10:53:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/TG-Therapeutics-Presents-Phase-1-Azer-cel-Data-in-Progressive-Multiple-Sclerosis-at-MSToronto-2026_11zon.webp https://thepharmadata.com/genmabs-rina-s-shows-significant-pfs-and/ 2026-10-24T10:59:35+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Genmabs-Rina-S-Shows-Significant-PFS-and-OS-Benefits-in-Platinum-Resistant-Ovarian-Cancer.webp https://thepharmadata.com/roche-reports-phase-3-data-showing-sefaxersen/ 2026-10-24T11:16:42+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Roche-Reports-Phase-3-Data-Showing-Sefaxersen-Significantly-Reduces-Proteinuria-in-IgA-Nephropathy_11zon.webp https://thepharmadata.com/povetacicept-phase-3-rainier-kidney-week-2026/ 2026-10-24T11:23:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Povetacicept-Phase-3-RAINIER-Results-Published-in-NEJM-Presented-at-ASN-Kidney-Week-2026_11zon.webp https://thepharmadata.com/gondolabio-and-childrens-tumor-foundation/ 2026-10-24T11:28:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/GondolaBio-and-Childrens-Tumor-Foundation-Partner-to-Advance-Neurofibromatosis-Type-1-Program.webp https://thepharmadata.com/heartbeams-heart-attack-assessment-technology/ 2026-10-27T10:36:18+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/HeartBeams-Heart-Attack-Assessment-Technology-Accepted-into-FDAs-TAP-Program.webp https://thepharmadata.com/pharmaessentia-to-showcase-early-stage-pipeline/ 2026-10-27T10:41:59+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/PharmaEssentia-to-Showcase-Early-Stage-Pipeline-Data-for-Solid-Tumor-Immunotherapy-at-SITC-Annual-Meeting_11zon.webp https://thepharmadata.com/naphcare-advances-correctional-healthcare/ 2026-10-27T10:46:39+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/NaphCare-Advances-Correctional-Healthcare-Technology-at-Annual-TechCare-User-Group_11zon.webp https://thepharmadata.com/align-technology-pledges-additional-1-million/ 2026-10-27T10:51:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Align-Technology-Pledges-Additional-1-Million-to-Support-Future-Orthodontic-Educators-and-Leaders_11zon.webp https://thepharmadata.com/dong-a-st-highlights-preclinical-potential/ 2026-10-27T11:01:15+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Dong-A-ST-Highlights-Preclinical-Potential-of-Topical-Icotrokinra-for-Psoriasis-Treatment-2_11zon.webp https://thepharmadata.com/incyte-presents-new-data-advancing-at-esmo-2026/ 2026-10-27T11:08:02+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Incyte-Presents-New-Data-Advancing-Gastrointestinal-Cancer-Pipeline-at-ESMO-2026_11zon.webp https://thepharmadata.com/sacituzumab-tirumotecan-advanced-endometrial/ 2026-10-27T11:18:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Sacituzumab-Tirumotecan-Cuts-Death-Risk-by-32-and-Disease-Progression-Risk-by-41-in-Advanced-Endometrial-Cancer_11zon.webp https://thepharmadata.com/rumi-therapeutics-licenses-ind-ready-rtx-7340/ 2026-10-28T10:10:48+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Rumi-Therapeutics-Licenses-IND-Ready-PDE2-Inhibitor-RTX-7340-to-Enthorin-Therapeutics-for-Fragile-X-Syndrome-Development_11zon.webp https://thepharmadata.com/powerful-medical-secures-cpt-code-for-ai-powered/ 2026-10-28T10:19:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Powerful-Medical-Secures-CPT-Code-for-AI-Powered-Heart-Attack-Detection-Following-FDA-Authorization-of-Queen-of-Hearts™.webp https://thepharmadata.com/laxxon-medical-names-matthew-cascio-president/ 2026-10-28T10:30:42+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Laxxon-Medical-Names-Matthew-Cascio-Vice-President-and-Head-of-Business-Development_11zon.webp https://thepharmadata.com/avanzanite-bioscience-strengthens-uk-appointment/ 2026-10-28T10:41:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Avanzanite-Bioscience-Strengthens-UK-Operations-with-Appointment-of-Sarah-OConnell-as-Country-Manager.webp https://thepharmadata.com/redemplo-plozasiran-offers-new-triglyceride/ 2026-10-28T10:51:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/REDEMPLO®-Plozasiran-Offers-New-Triglyceride-Lowering-Treatment-Option-for-Adults-with-FCS-in-England-and-Wales.webp https://thepharmadata.com/monebo-and-innolitics-obtain-fda-510-clearance/ 2026-10-28T11:21:04+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Monebo-and-Innolitics-Obtain-FDA-510k-Clearance-for-Cross-Platform-ECG-Arrhythmia-Analysis-Software-Library_11zon.webp https://thepharmadata.com/walmart-and-care-access-to-open-three-clinical/ 2026-10-28T11:25:21+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Walmart-and-Care-Access-to-Open-Three-New-Clinical-Trial-Centers-to-Expand-Access-to-Medical-Research_11zon.webp https://thepharmadata.com/la-times-publishing-launches-breakthroughs/ 2026-10-29T09:59:09+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/LA-Times-Publishing-Launches-Journal-of-Breakthroughs-in-Medicine-Science-to-Address-Gaps-in-Scientific-Publishing_11zon.webp https://thepharmadata.com/adjuvia-therapeutics-launches-phase-1-clinical/ 2026-10-29T10:03:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Adjuvia-Therapeutics-Launches-Phase-1-Clinical-Trial-of-ATI-105-for-Friedreichs-Ataxia.webp https://thepharmadata.com/strand-therapeutics-doses-clinical-trial-003/ 2026-10-29T10:08:14+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Strand-Therapeutics-Doses-First-Patients-in-Clinical-Trial-of-STX-003-a-Tumor-Selective-Programmable-mRNA-Therapy_11zon.webp https://thepharmadata.com/prilenia-and-ferrer-to-present-pridopidine-2026/ 2026-10-29T10:14:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Prilenia-and-Ferrer-to-Present-Pridopidine-Data-at-NEALS-2026_11zon.webp https://thepharmadata.com/blue-arbor-technologies-secures-10-5-million/ 2026-10-29T10:19:11+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Blue-Arbor-Technologies-Secures-10.5-Million-in-Series-A-Funding-Led-by-Ottobock_11zon.webp https://thepharmadata.com/gt-metabolic-solutions-secures-series-c-growth/ 2026-10-29T10:32:40+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/GT-Metabolic-Solutions-Secures-Series-C-Growth-Investment-Led-by-J.P.-Morgan-Life-Sciences-Private-Capital_11zon.webp https://thepharmadata.com/genmab-reports-significant-survival-and-response/ 2026-10-29T10:38:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Genmab-Reports-Significant-Survival-and-Response-Benefits-with-Petosemtamab-Combination-in-First-Line-Head-and-Neck-Cancer_11zon.webp https://thepharmadata.com/city-of-hope-honors-primary-wave-ce-larry-mestel/ 2026-10-29T10:51:41+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/City-of-Hope-Honors-Primary-Wave-CEO-Larry-Mestel-at-Spirit-of-Life-Gala_11zon.webp https://thepharmadata.com/align-technology-announces-leadership-transition/ 2026-10-29T10:59:28+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Align-Technology-Announces-Leadership-Transition-and-CEO-Succession-Plan_11zon.webp https://thepharmadata.com/ahf-calls-on-african-nations-strengthen-control/ 2026-10-31T09:47:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/AHF-Calls-on-African-Nations-to-Strengthen-Control-Over-Medicines-Regulation_11zon.webp https://thepharmadata.com/parse-biosciences-and-nomic-unveil-100-million/ 2026-10-31T09:54:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Parse-Biosciences-and-Nomic-Unveil-100-Million-Cell-AI-Ready-Dataset-for-Immune-Biology_11zon.webp https://thepharmadata.com/international-ginseng-symposium-highlights/ 2026-10-31T10:00:10+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/International-Ginseng-Symposium-Highlights-Red-Ginsengs-Anti-Aging-Mechanisms.webp https://thepharmadata.com/ingersoll-rand-bolsters-leadership-team/ 2026-10-31T10:05:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Ingersoll-Rand-Bolsters-Leadership-Team-to-Drive-Future-Growth_11zon.webp https://thepharmadata.com/setara-biosciences-raises-90m-series-a-advance/ 2026-10-31T10:11:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Setara-Biosciences-Raises-90M-Series-A-to-Advance-Rare-Disease-Therapies_11zon.webp https://thepharmadata.com/alkermes-launches-phase-2-study-of-alks-7290-for/ 2026-10-31T10:20:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Alkermes-Launches-Phase-2-Study-of-ALKS-7290-for-Major-Depressive-Disorder_11zon.webp https://thepharmadata.com/latus-bio-presents-promising-engineered-aav/ 2026-10-31T10:26:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Latus-Bio-Presents-Promising-Engineered-AAV-Capsid-Data-for-Kidney-and-CNS-Diseases-at-ESGCT-Congress_11zon.webp https://thepharmadata.com/enhertu-wins-2026-international-prix-galien/ 2026-10-31T10:36:18+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Enhertu-Wins-2026-International-Prix-Galien-Award-for-Best-Biotechnology-Product_11zon.webp https://thepharmadata.com/pretzel-therapeutics-secures-uk-approval-px578/ 2026-10-31T10:43:17+05:30 https://thepharmadata.com/wp-content/uploads/2026/10/Pretzel-Therapeutics-Secures-UK-Approval-to-Advance-PX578-Into-Clinical-Trials-for-POLG-Related-Mitochondrial-Disorders_11zon.webp https://thepharmadata.com/kairos-pharma-presents-at-international-cancer/ 2026-11-04T10:04:03+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Kairos-Pharma-Presents-at-International-Cancer-Research-Conference_11zon.webp https://thepharmadata.com/vintabio-offers-viral-vector-manufacturing/ 2026-11-04T10:08:58+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/VintaBio-Offers-Viral-Vector-Manufacturing-Facility-and-Technology-Assets-for-Acquisition_11zon.webp https://thepharmadata.com/agenus-reports-positive-phase-2-botbal-results/ 2026-11-04T10:14:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Agenus-Reports-Positive-Phase-2-BOTBAL-Results-in-Resectable-Colon-Cancer-Published-in-Nature-Medicine_11zon.webp https://thepharmadata.com/city-of-hope-researchers-explore-microbiome/ 2026-11-04T10:19:51+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/City-of-Hope-Researchers-Explore-Microbiome-Based-Approach-to-Prevent-Bloodstream-Infections_11zon.webp https://thepharmadata.com/ropeginterferon-alfa-2b-secures-et-approvals/ 2026-11-04T10:29:45+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Ropeginterferon-Alfa-2b-Secures-ET-Approvals-in-Key-Global-Markets-Expanding-Patient-Access_11zon.webp https://thepharmadata.com/imperative-care-reports-promising-safety-finding/ 2026-11-04T10:36:04+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Imperative-Care-Reports-Promising-Safety-Findings-in-Women-with-Pulmonary-Embolism-in-First-of-Its-Kind-Analysis_11zon.webp https://thepharmadata.com/mirum-pharmaceuticals-announces-quarter-2026/ 2026-11-04T10:41:54+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Mirum-Pharmaceuticals-Announces-Third-Quarter-2026-Financial-Results-and-Key-Business-Developments.jpg https://thepharmadata.com/sun-nuclear-introduces-simon-a-centralized/ 2026-11-04T10:52:22+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Sun-Nuclear-Introduces-Simon-a-Centralized-Command-Center-to-Monitor-Linac-Performance-in-Radiation-Oncology_11zon.webp https://thepharmadata.com/biolife-to-highlight-innovative-oral-peptide/ 2026-11-04T10:57:52+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/BioLife-to-Highlight-Innovative-Oral-Peptide-Delivery-Technology-at-London-Life-Sciences-Week_11zon.webp https://thepharmadata.com/immunome-to-unveil-initial-first-in-human-1021/ 2026-11-05T10:08:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Immunome-to-Unveil-Initial-First-in-Human-IM-1021-Clinical-Data-in-Advanced-B-Cell-Lymphomas-at-ASH-2026_11zon.webp https://thepharmadata.com/beone-medicines-brukinsa-combination-receives/ 2026-11-05T10:15:23+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/BeOne-Medicines-BRUKINSA-Combination-Receives-FDA-Priority-Review-for-First-Line-Mantle-Cell-Lymphoma.webp https://thepharmadata.com/penn-biontech-innovative-therapeutics-seed-fund/ 2026-11-05T10:20:34+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Penn-BioNTech-Innovative-Therapeutics-Seed-Fund-Unveils-Its-First-Investment-to-Advance-Therapeutic-Innovation_11zon.webp https://thepharmadata.com/polaris-rx-chosen-by-bristol-myers-squibb/ 2026-11-05T10:28:13+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Polaris-Rx-Chosen-by-Bristol-Myers-Squibb-to-Distribute-ZENBEXUS™-the-First-FDA-Approved-CELMoD-Treatment-for-Multiple-Myeloma.webp https://thepharmadata.com/global-healthy-living-foundation-highlights/ 2026-11-05T10:34:00+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Global-Healthy-Living-Foundation-Highlights-Advances-in-Myositis-and-Polymyalgia-Rheumatica-Research-at-ACR-Convergence-2026_11zon.webp https://thepharmadata.com/emeranova-strengthens-innovation-leadership/ 2026-11-05T10:40:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/EmeraNova™-Strengthens-Innovation-Leadership-with-Launch-of-New-Accelerator-Program.webp https://thepharmadata.com/natera-announces-executive-leadership-transition/ 2026-11-07T09:47:32+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Natera-Announces-Executive-Leadership-Transition_11zon.webp https://thepharmadata.com/tandem-diabetes-care-appoints-jeannette-bankes/ 2026-11-07T09:58:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Tandem-Diabetes-Care-Appoints-Jeannette-Bankes-as-President-and-CEO_11zon.webp https://thepharmadata.com/revelation-biosciences-reports-third-month-2026/ 2026-11-07T10:04:19+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Revelation-Biosciences-Reports-Third-Quarter-and-Nine-Month-2026-Financial-Results_11zon.webp https://thepharmadata.com/maat-pharma-shares-preliminary-phase-2a-picasso/ 2026-11-07T10:09:42+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/MaaT-Pharma-Shares-Preliminary-Phase-2a-PICASSO-Trial-Findings-in-Metastatic-Melanoma_11zon.webp https://thepharmadata.com/pulse-biosciences-reports-six-month-precise-btn/ 2026-11-07T10:17:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Pulse-Biosciences-Reports-Six-Month-PRECISE-BTN-Study-Results-at-ATA-Annual-Meeting_11zon.webp https://thepharmadata.com/front-range-pharmaceuticals-secures-fda-fast/ 2026-11-07T10:23:49+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Front-Range-Pharmaceuticals-Secures-FDA-Fast-Track-Designation-for-Long-COVID-Candidate-FRP-003_11zon.webp https://thepharmadata.com/indapta-therapeutics-to-present-idp-023-clinical/ 2026-11-07T10:29:29+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Indapta-Therapeutics-to-Present-IDP-023-Clinical-Data-in-Multiple-Myeloma-at-SITC-2026_11zon.webp https://thepharmadata.com/agenus-reports-long-term-survival-benefits-with/ 2026-11-07T10:34:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Agenus-Reports-Long-Term-Survival-Benefits-with-BOTBAL-in-Refractory-Colorectal-Cancer-at-SITC-2026_11zon.webp https://thepharmadata.com/onchilles-pharma-presents-first-clinical-17350/ 2026-11-07T10:38:47+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Onchilles-Pharma-Presents-First-Clinical-Data-for-N17350-as-a-Potential-Personalized-Cancer-Vaccine-at-SITC-2026_11zon.webp https://thepharmadata.com/aulos-bioscience-reports-promising-phase-2/ 2026-11-07T10:45:43+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Aulos-Bioscience-Reports-Promising-Phase-2-Imneskibart-Results-in-Melanoma-and-Lung-Cancer_11zon.webp https://thepharmadata.com/obsidian-therapeutics-to-present-updated-amsoki/ 2026-11-07T11:00:19+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Obsidian-Therapeutics-to-Present-Updated-Amsoki-cel-Clinical-Data-in-Advanced-Melanoma-at-SITC-2026_11zon.webp https://thepharmadata.com/lenacapavir-demonstrates-nearly-double-the-one/ 2026-11-07T11:10:56+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Lenacapavir-Demonstrates-Nearly-Double-the-One-Year-Persistence-of-Daily-Oral-FTDF-for-HIV-Prevention_11zon.webp https://thepharmadata.com/bristol-myers-squibb-presents-56-week-phase-3/ 2026-11-07T11:18:07+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Bristol-Myers-Squibb-Presents-56-Week-Phase-3-Camzyos-Data-in-Pediatric-oHCM-Patients-at-HCMS-2026_11zon.webp https://thepharmadata.com/kardigan-completes-phase-2b-katalyst-av-trial/ 2026-11-07T11:23:36+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Kardigan-Completes-Phase-2b-KATALYST-AV-Trial-Enrollment-for-Ataciguat-in-Aortic-Stenosis_11zon.webp https://thepharmadata.com/spruce-biosciences-announces-third-quarter-2026/ 2026-11-10T11:40:26+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Spruce-Biosciences-Announces-Third-Quarter-2026-Financial-Results-and-Key-Corporate-Developments_11zon.webp https://thepharmadata.com/antech-study-shows-keyscreen-detects-twice/ 2026-11-10T11:45:24+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Antech-Study-Shows-KeyScreen™-Detects-Twice-as-Many-Parasite-Positive-Samples-as-Two-Standard-Screening-Methods-Combined.webp https://thepharmadata.com/101-therapeutics-presents-positive-phase-2-3/ 2026-11-10T11:51:01+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/101-Therapeutics-Presents-Positive-Phase-23-Data-for-Macrophage-Targeted-101-PGC-005-at-ACR-2026_11zon.webp https://thepharmadata.com/corsair-pharma-reports-positive-meeting-trx-248/ 2026-11-10T12:24:48+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Corsair-Pharma-Reports-Positive-FDA-Pre-IND-Meeting-Outcome-for-TRX-248-PAH-Treatment_11zon.webp https://thepharmadata.com/xencor-presents-initial-plamotamab-data/ 2026-11-10T12:31:30+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Xencor-Presents-Initial-Plamotamab-Data-in-Rheumatoid-Arthritis-and-Updates-XmAb657-Clinical-Progress-at-ACR-2026_11zon.webp https://thepharmadata.com/alpha-cognition-appoints-caren-deardorf-to-its/ 2026-11-10T12:48:55+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Alpha-Cognition-Appoints-Caren-Deardorf-to-Its-Board-of-Directors_11zon.webp https://thepharmadata.com/everleap-expands-fertility-services-with-new/ 2026-11-10T12:48:16+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Everleap-Expands-Fertility-Services-with-New-Clinic-in-The-Woodlands-Texas_11zon.webp https://thepharmadata.com/biocodex-invests-e15-million-to-establish-new/ 2026-11-11T12:05:15+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Biocodex-Invests-E15-Million-to-Establish-New-Manufacturing-Platform-for-Live-Biotherapeutic-Products.webp https://thepharmadata.com/dreem-health-and-withings-partner-to-transform/ 2026-11-11T12:12:02+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Dreem-Health-and-Withings-Partner-to-Transform-Sleep-Tracking-Into-Comprehensive-Sleep-Care_11zon.webp https://thepharmadata.com/carequest-and-henry-schein-launch-bridge-heal/ 2026-11-11T12:17:51+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/CareQuest-and-Henry-Schein-Launch-BRIDGE-Health-Network-to-Strengthen-Dental-Medical-Integration_11zon.webp https://thepharmadata.com/immunis-recognized-as-2026s-top-biotech/ 2026-11-11T12:27:27+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Immunis-Recognized-as-2026s-Top-Biotech-and-Life-Sciences-Company-by-Healthcare-Technology-Report.webp https://thepharmadata.com/programmable-medicine-showcases-myeloid-acr-2026/ 2026-11-11T12:32:08+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Programmable-Medicine-Showcases-Myeloid-Targeted-JAK-Inhibitors-Aimed-at-Improving-Rheumatoid-Arthritis-Treatment-Safety-at-ACR-2026_11zon.webp https://thepharmadata.com/ntt-research-accelerates-cardiovascular-digital/ 2026-11-11T12:42:41+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/NTT-Research-Accelerates-Cardiovascular-Digital-Twin-Development-Using-a-Precomputed-Virtual-Population_11zon.webp https://thepharmadata.com/within3-names-ira-daly-as-chief-operating/ 2026-11-11T12:51:57+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/Within3-Names-Ira-Daly-as-Chief-Operating-Officer_11zon.webp https://thepharmadata.com/astrazeneca-awards-1-6million-expand-healthcare/ 2026-11-11T13:00:18+05:30 https://thepharmadata.com/wp-content/uploads/2026/11/AstraZeneca-Awards-1.6-Million-to-Expand-Healthcare-Access-for-Patients-Across-the-United-States_11zon.webp